Records containing: Varicella
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2016-09-21Blinded, Randomised Study to Assess the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Live Attenuated Measles-mumps-rubella-varicella Candidate Vaccine When Given to Healthy Children in Their Second Year of Life
-
CLINICAL_TRIALS study record update · 2016-09-15Follow-up to Evaluate the the Immunogenicity & Safety of GSK Biologicals' MMRV Vaccine Given as a Two-dose Schedule in the Second Year of Life, as Compared to Separate Administration of GSK Biologicals' Priorix® & Varilrix®.
-
CLINICAL_TRIALS study record update · 2016-07-11Study of Immunogenicity, Reactogenicity and Safety of the Combined Measles, Mumps and Rubella Vaccine Produced by Bio-Manguinhos/Fiocruz in Children 12-15 Months of Age, Followed by Tetraviral Vaccine in Children 15-18 Months.
-
CLINICAL_TRIALS study record update · 2016-03-01A Phase III Double Blind, Randomized, Multicenter, Controlled Study to Evaluate the Immunogenicity, Safety, and Tolerability of VARIVAX™ New Seed Process (NSP) Administered Concomitantly With M-M-R™ II
-
CLINICAL_TRIALS study record update · 2015-10-23A Study of M-M-R(TM) II at Mumps Expiry Potency in Healthy Children 12 to 18 Months of Age
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2015-04-15Clinical Evaluation of Valaciclovir Hydrochloride: 256U87 in Patients With Chickenpox - Open Uncontrolled Study.
-
CLINICAL_TRIALS study record update · 2015-01-27A Phase III Double Blind, Randomized, Multicenter, Controlled Study to Evaluate the Immunogenicity, Safety and Tolerability of VARIVAX Made With the Varicella Enhanced Process (VEP)
-
CLINICAL_TRIALS study record update · 2014-09-01A Study to Evaluate the Immunogenicity and Safety of 2 Doses of Live Attenuated Varicella Vaccine
-
CLINICAL_TRIALS study record update · 2014-07-02A Phase III Double-Blind, Randomized, Multicenter, Controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of Measles, Mumps, Rubella, Varicella (MMRV) Vaccine Made With an Alternative Manufacturing Process (AMP)
-
CLINICAL_TRIALS study record update · 2014-05-23Study on Effectiveness of 2-dose Live Attenuated Varicella Vaccine
-
CLINICAL_TRIALS study record update · 2013-07-22Post-marketing Surveillance Study of GSK Biologicals' Live, Attenuated Measles, Mumps, Rubella and Varicella Vaccine, Priorix-Tetra, Following a Single Vaccine Dose Given According to Local Prescribing Information in the Philippines
-
CLINICAL_TRIALS study record update · 2013-07-03Re-examination Study for General Vaccine Use to Assess the Safety Profile of Varivax in Usual Practice
-
CLINICAL_TRIALS study record update · 2013-06-26Phase 4 Study of Live Attenuated Varicella Vaccine After the 2 Doses Vaccination
-
CLINICAL_TRIALS study record update · 2013-06-25Evaluation of Vaccination Reminder/Recall Systems for Adolescent Patients
-
CLINICAL_TRIALS study record update · 2013-06-10Safety of a Second Dose of Biken's Varicella Vaccine Administered at 4 to 6 Years of Age in Healthy Children in Argentina
-
CLINICAL_TRIALS study record update · 2013-05-29Phase 4 Study of the Varicella Vaccine After the 2nd Dose Vaccination
-
CLINICAL_TRIALS study record update · 2013-04-04Safety and Efficacy of Varicella Zoster Immune Globulin (Human) VariZIG in Patients at Risk of Varicella Infection
-
CLINICAL_TRIALS study record update · 2012-10-10A Multicenter, Randomized, Open-Label Study to Compare the Immunogenicity, Safety, and Tolerability of Measles, Mumps, Rubella, and Varicella of Combination Vaccine ProQuad With Concomitant Administration of M-M-R II and VARIVAX in Healthy Korean Children
-
CLINICAL_TRIALS study record update · 2011-11-03Fifteen Year Follow-up to Evaluate Long-term Effectiveness of VARIVAX Among Children and Adolescents
-
CLINICAL_TRIALS study record update · 2011-09-26Special Drug Use Investigation for VALTREX (Valaciclovir) (Pediatrics Chickenpox)
-
CLINICAL_TRIALS study record update · 2011-07-06Safety Study of Menactra® (Meningococcal [Groups A, C, Y and W-135] Polysaccharide Diphtheria Toxoid Conjugate Vaccine) When Administered With Other Pediatric Vaccines to Healthy Toddlers
-
CLINICAL_TRIALS study record update · 2011-06-02An Immunogenicity and Safety Evaluation of Two Doses of Menactra® (Meningococcal [Groups A, C, Y and W-135] Polysaccharide Diphtheria Toxoid Conjugate Vaccine) Given to Healthy Subjects at 9 and 12 Months of Age
-
CLINICAL_TRIALS study record update · 2011-06-02An Immunogenicity, Safety, and Non-Interference Evaluation of Pediatric Vaccines Administered Concomitantly With Menactra® (Meningococcal [Groups A, C, Y and W-135] Polysaccharide Diphtheria Toxoid Conjugate Vaccine) to Healthy Toddlers
-
CLINICAL_TRIALS study record update · 2011-04-21Safety, Tolerability, and Immunogenicity of VARIVAX (2007 Commercial VZV Bulk Process) Administered Concomitantly With M-M-R II in Healthy Children 12-to-23 Months of Age
-
CLINICAL_TRIALS study record update · 2010-08-27MMR and Varicella Vaccine Responses in Extremely Premature Infants